Carcinogenicity of Inhaled Plutonium-238 in the Rat
Copyright policy )Carcinogenicity of Inhaled Plutonium-238 in the Rat
III). Only 1% of the initial alveolar lung burden remained in the lung at 1 year, decreasing to 0.3% by 600 days after exposure. The 23Pu body burden was 25% of initial alveolar burden at 1 year, decreasing to 12% by 1000 days after exposure; about half of the body burden was found in the skeleton at these times. The cumulative radiation doses to the lung at 2 years after exposure were 9 rads (I), 32 rads (II), and 375 rads (III). Unexposed controls exhibited a median survival tine of 825 days as compared to experimental survival times of 650 days (I), 675 days (II), and 550 days (III). The incidence of lung tumors in controls was 1.1% as compared to incidences in 23Pu-exposed rats of 6.6% (I), 20.0% (II), and 25.0% (III). The incidence of all tumors, other than mammary tumors, was 4.3% in unexposed controls, and in 238Pu-exposed rats, 26.7% (I),
- University of North Texas United States
Lung Neoplasms, Neoplasms, Radiation-Induced, Carcinogenesis, Radiation Doses, *Plutonium 238-- Biological Radiation Effects, Adrenal Gland Neoplasms, *Neoplasms-- Radioinduction, Adenocarcinoma, Nesdps Office Of Nuclear Energy Space And Defense Power Systems, Intestinal Neoplasms, *Lungs-- Radionuclide Kinetics, Radioactive Aerosols, Plutonium Oxides, Animals, Retention Radioinduction Nesdps Office Of Nuclear Energy Space And Defense Power Systems, Ovarian Neoplasms, Osteosarcoma, Lymphoma, Non-Hodgkin, Mammary Neoplasms, Experimental, Neoplasms, Experimental, Adenocarcinoma, Bronchiolo-Alveolar, Kidney Neoplasms, Plutonium, Rats, Pancreatic Neoplasms, Dose-Response Relationships, Inhalation, Leukemia, Myeloid, Abdominal Neoplasms, N48620* --Life Sciences--Radionuclide Effects (Internal Source)--Animals, Carcinoma, Squamous Cell, Female, *Skeleton-- Radionuclide Kinetics, Adenofibroma
Lung Neoplasms, Neoplasms, Radiation-Induced, Carcinogenesis, Radiation Doses, *Plutonium 238-- Biological Radiation Effects, Adrenal Gland Neoplasms, *Neoplasms-- Radioinduction, Adenocarcinoma, Nesdps Office Of Nuclear Energy Space And Defense Power Systems, Intestinal Neoplasms, *Lungs-- Radionuclide Kinetics, Radioactive Aerosols, Plutonium Oxides, Animals, Retention Radioinduction Nesdps Office Of Nuclear Energy Space And Defense Power Systems, Ovarian Neoplasms, Osteosarcoma, Lymphoma, Non-Hodgkin, Mammary Neoplasms, Experimental, Neoplasms, Experimental, Adenocarcinoma, Bronchiolo-Alveolar, Kidney Neoplasms, Plutonium, Rats, Pancreatic Neoplasms, Dose-Response Relationships, Inhalation, Leukemia, Myeloid, Abdominal Neoplasms, N48620* --Life Sciences--Radionuclide Effects (Internal Source)--Animals, Carcinoma, Squamous Cell, Female, *Skeleton-- Radionuclide Kinetics, Adenofibroma
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).35 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!